GlobeNewsWire
10 Aug 2026, 10:46 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Capricor Therapeutics experienced a 64% decline in its stock price. — A massive drop in share price indicates a significant loss of market capitalization and investor confidence.
-0.80A securities class action lawsuit has been initiated against Capricor Therapeutics. — Legal action for securities fraud creates financial liability and introduces systemic risk to the company's reputation.
-0.50Which stocks this story touches
The company is facing a securities class action lawsuit following a 64% drop in stock price.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
5h ago
